PI
WST icon

Putnam Investments’s West Pharmaceutical WST Stock Holding History

Putnam Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.67M Buy
4,740
+748
+19% +$265K ﹤0.01% 782
2023
Q3 		$1.5M Buy
+3,992
New +$1.54M ﹤0.01% 776
2020
Q3 		– Sell
-39,693
Closed -$9.02M – 914
2020
Q2 		$9.02M Sell
39,693
-19,188
-33% -$3.77M 0.02% 350
2020
Q1 		$8.96M Buy
+58,881
New +$9.06M 0.02% 341
2016
Q2 		– Sell
-60,028
Closed -$4.16M – 1418
2016
Q1 		$4.16M Buy
60,028
+1,164
+2% +$70K 0.01% 705
2015
Q4 		$3.54M Sell
58,864
-600
-1% -$36.1K 0.01% 796
2015
Q3 		$3.22M Buy
59,464
+1,812
+3% +$106K 0.01% 831
2015
Q2 		$3.35M Sell
57,652
-50
-0.1% -$2.79K 0.01% 880
2015
Q1 		$3.47M Sell
57,702
-1,930
-3% -$103K 0.01% 891
2014
Q4 		$3.17M Sell
59,632
-1,544
-3% -$77.2K 0.01% 894
2014
Q3 		$2.74M Buy
+61,176
New +$2.6M 0.01% 945
2013
Q3 		– Sell
-283,000
Closed -$9.94M – 1500
2013
Q2 		$9.94M Buy
+283,000
New +$9.31M 0.03% 418

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments's WST Position: Q4 2023 in Review

Putnam Investments increased its West Pharmaceutical (WST) stake by 19% in Q4 2023, buying an estimated $265K and bringing the position to 4,740 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Putnam Investments first reported a position in WST in Q2 2013 and has held it in 12 quarters since. The position peaked at $9.94M in Q2 2013. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Putnam Investments held 4,740 shares of West Pharmaceutical worth $1.67M as of Q4 2023.
  • Putnam Investments bought 748 West Pharmaceutical shares in Q4 2023, an estimated $265K.
  • West Pharmaceutical made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #782 holding.
  • Putnam Investments first reported a position in West Pharmaceutical in Q2 2013 and has held it in 12 quarters since.
  • Putnam Investments's West Pharmaceutical position peaked at $9.94M in Q2 2013.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.